Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Solomon

Showing results (251-260 of 1,423) with videos related to

Pageof 143
Sort By:
JACC. Heart Failure|March 5, 2018
Natriuretic Peptides as Biomarkers of Treatment Response in Clinical Trials of Heart FailureMuthiah Vaduganathan, Brian Claggett, Milton Packer, et al.
Circulation. Heart Failure|August 14, 2013
Race influences the safety and efficacy of spironolactone in severe heart failureOrly Vardeny, Larisa H Cavallari, Brian Claggett, et al.
JACC. Basic to Translational Science|September 5, 2022
A Phase 1 Dose-Escalation Study of the Cardiac Myosin Inhibitor Aficamten in Healthy ParticipantsFady I Malik, Laura A Robertson, Danielle R Armas, et al.
American Heart Journal|July 7, 2020
Transcatheter InterAtrial Shunt Device for the treatment of heart failure: Rationale and design of the pivotal randomized trial to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure II (REDUCE LAP-HF II)Natalia Berry, Laura Mauri, Ted Feldman, et al.
Circulation|March 14, 2018
Widening Racial Differences in Risks for Coronary Heart DiseaseWilson Nadruz, Brian Claggett, Mir Henglin, et al.
Journal of the American Society of Nephrology : JASN|August 25, 2006
Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarctionPowell Jose, Hicham Skali, Nagesh Anavekar, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|July 13, 2011
Suppression of aldosterone mediates regression of left ventricular hypertrophy in patients with hypertensionAnne-Catherine Pouleur, Hajime Uno, Margaret F Prescott, et al.
ESC Heart Failure|March 29, 2023
Predictive value of global longitudinal strain by left ventricular ejection fractionDiego Medvedofsky, Genevieve Arany-Lao-Kan, Scott McNitt, et al.
The American Journal of Medicine|February 15, 2003
Value of the electrocardiogram in predicting left ventricular enlargement and dysfunction after myocardial infarctionCostantina Manes, Marc A Pfeffer, John D Rutherford, et al.
Hypertension (Dallas, Tex. : 1979)|July 24, 2013
Differential influence of distinct components of increased blood pressure on cardiovascular outcomes: from the atherosclerosis risk in communities studySusan Cheng, Deepak K Gupta, Brian Claggett, et al.
Pageof 143

Showing results (251-260 of 1,423) with videos related to

Sort By:
Pageof 143
JACC. Heart Failure|March 5, 2018
Natriuretic Peptides as Biomarkers of Treatment Response in Clinical Trials of Heart FailureMuthiah Vaduganathan, Brian Claggett, Milton Packer, et al.
Circulation. Heart Failure|August 14, 2013
Race influences the safety and efficacy of spironolactone in severe heart failureOrly Vardeny, Larisa H Cavallari, Brian Claggett, et al.
JACC. Basic to Translational Science|September 5, 2022
A Phase 1 Dose-Escalation Study of the Cardiac Myosin Inhibitor Aficamten in Healthy ParticipantsFady I Malik, Laura A Robertson, Danielle R Armas, et al.
American Heart Journal|July 7, 2020
Transcatheter InterAtrial Shunt Device for the treatment of heart failure: Rationale and design of the pivotal randomized trial to REDUCE Elevated Left Atrial Pressure in Patients with Heart Failure II (REDUCE LAP-HF II)Natalia Berry, Laura Mauri, Ted Feldman, et al.
Circulation|March 14, 2018
Widening Racial Differences in Risks for Coronary Heart DiseaseWilson Nadruz, Brian Claggett, Mir Henglin, et al.
Journal of the American Society of Nephrology : JASN|August 25, 2006
Increase in creatinine and cardiovascular risk in patients with systolic dysfunction after myocardial infarctionPowell Jose, Hicham Skali, Nagesh Anavekar, et al.
Journal of the Renin-Angiotensin-Aldosterone System : JRAAS|July 13, 2011
Suppression of aldosterone mediates regression of left ventricular hypertrophy in patients with hypertensionAnne-Catherine Pouleur, Hajime Uno, Margaret F Prescott, et al.
ESC Heart Failure|March 29, 2023
Predictive value of global longitudinal strain by left ventricular ejection fractionDiego Medvedofsky, Genevieve Arany-Lao-Kan, Scott McNitt, et al.
The American Journal of Medicine|February 15, 2003
Value of the electrocardiogram in predicting left ventricular enlargement and dysfunction after myocardial infarctionCostantina Manes, Marc A Pfeffer, John D Rutherford, et al.
Hypertension (Dallas, Tex. : 1979)|July 24, 2013
Differential influence of distinct components of increased blood pressure on cardiovascular outcomes: from the atherosclerosis risk in communities studySusan Cheng, Deepak K Gupta, Brian Claggett, et al.
Pageof 143